Parental Perception of Comorbidities in Children With Dravet Syndrome

Kelly G Knupp1, Sharon Scarbro2, Greta Wilkening3

  • 1Department of Pediatrics and Neurology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado; ACCORDS (Adult and Child Consortium for Health Outcomes Research and Delivery Science), University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, Colorado.

Pediatric Neurology
|October 7, 2017
PubMed

Insights

Caregivers report numerous Dravet syndrome symptoms beyond seizures, including appetite, sleep, gait, and behavioral issues. These symptoms significantly impact the quality of life for children and their families.

Area of Science:

  • Pediatric Neurology
  • Genetics
  • Clinical Research

Background:

  • Dravet syndrome is primarily known for seizures and cognitive impairment.
  • A comprehensive understanding of associated symptoms is lacking.
  • Caregiver perceptions of additional symptoms require investigation.

Purpose of the Study:

  • To identify and quantify caregiver-perceived symptoms in children with Dravet syndrome.
  • To explore symptoms beyond seizures and cognitive deficits.
  • To assess the impact of these symptoms on quality of life.

Main Methods:

  • An electronic survey was distributed to caregivers of children with Dravet syndrome.
  • The survey utilized a four-point Likert scale to assess various symptoms.
  • Logistic regression and multivariable models were employed for data analysis.

Main Results:

  • 202 caregivers responded, predominantly parents (96%).
  • High prevalence of symptoms related to appetite (99%), sleep disturbances (82%), gait problems (75%), and behavioral issues (inattention, perseveration).
  • Autonomic symptoms were reported in one-third of participants.

Conclusions:

  • Caregivers perceive a wide range of symptoms in Dravet syndrome beyond established ones.
  • Appetite, sleep, gait, and behavior are commonly reported additional symptoms.
  • These symptoms significantly affect the quality of life for affected children and their caregivers.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.3K
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
894
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
660
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
38
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276